Clinical trialNCT06088381RecruitingPhase 2Interventional

Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)

SponsorUniversity of Maryland, BaltimoreEnrollment61HPV Positive Oropharyngeal Squamous Cell CarcinomaHead and Neck CancerHead and Neck Squamous Cell CarcinomaOropharynx CancerOropharynx Squamous Cell Carcinoma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Jason K Molitoris, MD, PhD
University of Maryland/Maryland Proton Treatment Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Maryland Proton Treatment Center
Baltimore, Maryland, United States
Recruiting
University of Maryland Greenebaum Cancer Center
Baltimore, Maryland, United States
Recruiting
Upper Chesapeake Health
Bel Air, Maryland, United States
Not, yet, recruiting
Central Maryland Radiation Oncology
Columbia, Maryland, United States
Not, yet, recruiting
Baltimore Washington Medical Center
Glen Burnie, Maryland, United States
Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 7 Mar 2024
Primary completion: 18 Dec 2028
Completion: 18 Dec 2030
Last update posted: 10 Nov 2025
Registered enrollment: 61
Registry id: NCT06088381

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.